Cherqaoui Driss - Profil du chercheur

Informations du chercheur

Nom complet

Cherqaoui Driss

Grade

PES

Spécialité

Chimie organique

Thématique de recherche

Synthèse organique et modélisation moléculaire

Laboratoire

Laboratoire de Chimie Moléculaire

Établissement

Faculté des Sciences Semlalia Marrakech

Ouvrages (0 au total)

Aucun ouvrage disponible.

Projets (1 au total)

Modélisation moléculaire : Contribution à la conception d’inhibiteurs du VIH

Type: Non spécifié

Début: 01/01/2017

Fin: 30/12/2018

Organisme financeur:

Agence Universitaire de la Francophonie” and the Scientific Research Fund of Bulgaria. under project DNTS/FrPh01/1.

Publications (29 au total)

Deciphering the cytotoxic and antioxidant potential of 3,5-disubstituted isoxazole-linked benzimidazolone derivatives

Auteur: Mohamed Adardour, Soufiane Drioua, Marouane Ait Lahcen, Ismail Hdoufane, Elena Zaballos-García, Mohammed M. Alanazi, Anass Doukkali, Karim Chkirate, Driss Cherqaoui, Joel T. Mague, Abdesselam Baouid

Revue: Journal of Molecular Structure

Année: 2025

DOI: 10.1016/j.molstruc.2024.139683

New Schiff bases and their vanadium complexes: Synthesis, characterization, and biological assessment for antibacterial and antiviral action

Auteur: Khadija Khaldoune, Ali Hasnaoui, Meryem Rafya, Meriem Es‐sakhi, Fatiha Benkhalti, Ismail Hdoufane, Joel T. Mague, Johan Neyts, Dirk Jochmans, Driss Cherqaoui, Larbi el Firdoussi, Naima Fdil, Hassan Bihi Lazrek, Mustapha Ait Ali

Revue: Applied Organometallic Chemistry

Année: 2024

DOI: 10.1002/aoc.7534

Drug design of new anti-EBOV inhibitors: QSAR, homology modeling, molecular docking and molecular dynamics studies

Auteur: Nouhaila Ait Lahcen, Wissal Liman, Mehdi Oubahmane, Ismail Hdoufane, Youssef Habibi, Ashwag S. Alanazi, Mohammed M. Alanazi, Christelle Delaite, Mohamed Maatallah, Driss Cherqaoui

Revue: Arabian Journal of Chemistry

Année: 2024

DOI: 10.1016/j.arabjc.2024.105870

Syntheses, characterization and DFT studies of two new (π-allyl) palladium(II) complexes of β-8,9-dihydrohimachalene

Auteur: Abdelmajid Faris, Youssef Edder, Ismail Hdoufane, Intissar Ait Lahcen, Mohamed Saadi, Lahcen EL Ammari, Moha Berraho, Driss Cherqaoui, Brahim Boualy, Abdallah Karim

Revue: Journal of Coordination Chemistry

Année: 2023

DOI: 10.1080/00958972.2023.2194013

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations

Auteur: Mehdi Oubahmane, Ismail Hdoufane, Christelle Delaite, Adlane Sayede, Driss Cherqaoui, Achraf El Allali

Revue: Pharmaceuticals

Année: 2023

DOI: 10.3390/ph16040608

Synthesis, characterization, X-ray, α-glucosidase inhibition and molecular docking study of new triazolic systems based on 1,5-benzodiazepine <i>via</i> 1,3-dipolar cycloaddition reactions

Auteur: Marouane Ait Lahcen, Mohamed Adardour, Salma Mortada, Mehdi Oubahmane, Samir Hmaimou, Mohamed Loughzail, Ismail Hdoufane, Sanae Lahmidi, My El Abbes Faouzi, Driss Cherqaoui, Joel T. Mague, Abdesselam Baouid

Revue: Journal of Biomolecular Structure and Dynamics

Année: 2023

DOI: 10.1080/07391102.2023.2203263

Exploring anticancer activity, acute toxicity, and molecular docking of synthesized schiff bases and schiff base-palladium complex

Auteur: Khadija Khaldoune, Ali Hasnaoui, Naima Fdil, Ali Oubella, Karima Lafhal, Mehdi Oubahmane, Ismail Hdoufane, Lahcen El Ammari, Mohamed Saadi, Moha Berraho, My Youssef Ait Itto, Larbi El Firdoussi, Mustapha Ait Ali

Revue: Inorganic Chemistry Communications

Année: 2023

DOI: 10.1016/j.inoche.2023.111089

Crystal Structure, DFT Calculation, and Hirshfeld Surface Analysis of the 1-(Cyclohex-1-en-1-yl)-3-(prop-2-yn-1-yl)-1,3-dihydro-2H-benzimidazol-2-one

Auteur: Mohamed Adardour, Marouane Ait Lahcen, Ismail Hdoufane, Mohammed M. Alanazi, Mohamed Loughzail, Hénia Mousser, Solenne Fleutot, Michel François, Driss Cherqaoui, Abdesselam Baouid

Revue: Crystals

Année: 2023

DOI: 10.3390/cryst13121661

Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants

Auteur: Mohamed Adardour, Marouane Ait Lahcen, Mehdi Oubahmane, Walid Ettahiri, Ismail Hdoufane, Hafida Bouamama, Mohammed M. Alanazi, Driss Cherqaoui, Mustapha Taleb, Elena Zaballos Garcia, Abdesselam Baouid

Revue: Pharmaceuticals

Année: 2023

DOI: 10.3390/ph16121648

1 2 3 Suivant »

Communications (22 au total)

In silico identification of novel NS5A inhibitors with potential anti-HCV activity

Manifestation: UM6P Doctoral Day 2023

Date: 2023-09-25

Organisation: Université Mohammed VI Polytechnique, Ben Guérir, Morocco

QSAR modeling, ADMET predictions and molecular docking analysis of a series of Dimeric phenylthiazole derivatives as NS5A inhibitors

Manifestation: 33th edition of the International Congress of “Apollonia” University of Iasi

Date: 2023-03-03

Organisation: Apollonia University of Iasi, Iasi, Roumanie

Identification of novel TMPRSS4 inhibitors via homology modeling, molecular docking and molecular dynamics

Manifestation: 33rd edition of the International Congress of “Apollonia” University of Iasi

Date: 2023-03-02

Organisation: Apollonia University of Iasi, Iasi, Roumanie

8. In silico studies toward the identification of potential glycoprotein inhibitors as anti-Ebola agents

Manifestation: 33rd edition of the International Congress of “Apollonia” University of Iasi

Date: 2023-03-02

Organisation: Apollonia University of Iasi, Iasi, Roumanie

Identification of new potential HCV inhibitors

Manifestation: International bioinformatics conference (IBC 2022):Drug Design

Date: 2022-10-08

Organisation: Tanger, Maroc

In Silico approaches for the design of HCV inhibitors

Manifestation: Science week talks

Date: 2022-05-31

Organisation: Université Mohammed VI Polytechnique, Ben Guérir, Morocco

In silico QSAR-based discovery and molecular docking of novel inhibitors of the SARS-COV-2 main protease (Mpro)

Manifestation: 32nd edition of the international congress of Apollonia University "Preparing the Future by Promoting Excellence"

Date: 2022-03-02

Organisation: Iasi, Romania

QSAR Study of NS5A Inhibitors against Hepatitis C Virus using the Monte Carlo Optimization and the Genetic Algorithm Multiple Linear Regression(GA-MLR) Models

Manifestation: 6th International Conference on Computational Science and Technology 2021-ICCST

Date: 2021-10-31

Organisation: Faculty of Pharmacy, Chiang Mai University, Thailand

In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2

Manifestation: 6th International Conference on Computation For Sciences and Technology

Date: 2021-10-30

Organisation: Thailand

1 2 3 Suivant »

Thèses (3 au total)

In Silico Drug Design of Potent SARS-CoV-2 Inhibitors

Auteur: Mehdi OUBAHMANE

Directeur: Cherqaoui Driss

Soutenance: 2023

Molecular Modeling: QSAR Studies on Reverse Transcriptase and Gp120 HIV-1 and NS4B HCV Inhibitors

Auteur: HDOUFANE Ismail

Directeur: Cherqaoui Driss

Soutenance: 2021

Targeting Protein Degradation as a Potential and Emerging Therapeutic Approach in Cancer Drug Discovery: Combinatorial In Silico Modeling to Explore the Covalent & Non-covalent Inhibition of Nedd4-1 E3 Ubiquitin Ligase

Auteur: BJIJ Imane

Directeur: Cherqaoui Driss

Soutenance: 2019

Informations du chercheur

Nom complet

Grade

Spécialité

Thématique de recherche

Laboratoire

Établissement

Ouvrages (0 au total)

Projets (1 au total)

Mod&eacute;lisation mol&eacute;culaire : Contribution &agrave; la conception d&rsquo;inhibiteurs du VIH

Publications (29 au total)

Deciphering the cytotoxic and antioxidant potential of 3,5-disubstituted isoxazole-linked benzimidazolone derivatives

New Schiff bases and their vanadium complexes: Synthesis, characterization, and biological assessment for antibacterial and antiviral action

Drug design of new anti-EBOV inhibitors: QSAR, homology modeling, molecular docking and molecular dynamics studies

Syntheses, characterization and DFT studies of two new (π-allyl) palladium(II) complexes of β-8,9-dihydrohimachalene

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations

Synthesis, characterization, X-ray, α-glucosidase inhibition and molecular docking study of new triazolic systems based on 1,5-benzodiazepine <i>via</i> 1,3-dipolar cycloaddition reactions

Exploring anticancer activity, acute toxicity, and molecular docking of synthesized schiff bases and schiff base-palladium complex

Crystal Structure, DFT Calculation, and Hirshfeld Surface Analysis of the 1-(Cyclohex-1-en-1-yl)-3-(prop-2-yn-1-yl)-1,3-dihydro-2H-benzimidazol-2-one

Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants

Communications (22 au total)

In silico identification of novel NS5A inhibitors with potential anti-HCV activity

QSAR modeling, ADMET predictions and molecular docking analysis of a series of Dimeric phenylthiazole derivatives as NS5A inhibitors

Identification of novel TMPRSS4 inhibitors via homology modeling, molecular docking and molecular dynamics

8. In silico studies toward the identification of potential glycoprotein inhibitors as anti-Ebola agents

Identification of new potential HCV inhibitors

In Silico approaches for the design of HCV inhibitors

In silico QSAR-based discovery and molecular docking of novel inhibitors of the SARS-COV-2 main protease (Mpro)

QSAR Study of NS5A Inhibitors against Hepatitis C Virus using the Monte Carlo Optimization and the Genetic Algorithm Multiple Linear Regression(GA-MLR) Models

In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2

Thèses (3 au total)

In Silico Drug Design of Potent SARS-CoV-2 Inhibitors

Molecular Modeling: QSAR Studies on Reverse Transcriptase and Gp120 HIV-1 and NS4B HCV Inhibitors

Targeting Protein Degradation as a Potential and Emerging Therapeutic Approach in Cancer Drug Discovery: Combinatorial In Silico Modeling to Explore the Covalent &amp; Non-covalent Inhibition of Nedd4-1 E3 Ubiquitin Ligase

Modélisation moléculaire : Contribution à la conception d’inhibiteurs du VIH

Targeting Protein Degradation as a Potential and Emerging Therapeutic Approach in Cancer Drug Discovery: Combinatorial In Silico Modeling to Explore the Covalent & Non-covalent Inhibition of Nedd4-1 E3 Ubiquitin Ligase